NASDAQ:GNOM Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News $8.10 -0.09 (-1.10%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$8.02 -0.07 (-0.93%) As of 04/25/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GNOM alerts:Sign Up Key Stats Today's Range$8.02▼$8.1550-Day Range$6.97▼$10.1752-Week Range$6.80▼$11.88Volume14,200 shsAverage Volume62,805 shsMarket Capitalization$49.09 millionAssets Under Management$49.08 millionDividend Yield0.00%Net Expense Ratio0.50%Aggregate RatingModerate Buy ETF OverviewComplete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.Read More… Global X Genomics & Biotechnology ETF ExpensesTypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.56%0.53%0.53%Other Expenses0.00%0.57%0.48%0.43%0.52%Total Expense0.50%0.73%0.72%0.67%0.71%Fee Waiver0.00%-0.71%-0.49%-0.29%-0.54%Net Expense0.50%0.60%0.63%0.61%0.60% Receive GNOM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address GNOM ETF News Headlines10x Genomics Misses Revenue ForecastOctober 29, 2024 | fool.comGlobal X Genomics & Biotechnology UCITS ETF (GNOM.L)August 18, 2024 | finance.yahoo.comTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.April 27, 2025 | American Alternative (Ad)GNOM Global X Genomics & Biotechnology ETFJuly 25, 2024 | seekingalpha.com3 Gene Editing Stocks with the Potential to Make You an Overnight MillionaireMay 2, 2024 | investorplace.comThe Analyst Landscape: 4 Takes On 10x GenomicsApril 18, 2024 | markets.businessinsider.comSee More Headlines GNOM ETF - Frequently Asked Questions How have GNOM shares performed this year? Global X Genomics & Biotechnology ETF's stock was trading at $9.71 on January 1st, 2025. Since then, GNOM stock has decreased by 16.6% and is now trading at $8.10. View the best growth stocks for 2025 here. Who are Global X Genomics & Biotechnology ETF's major shareholders? Top institutional investors of Global X Genomics & Biotechnology ETF include Oppenheimer Asset Management Inc. (1.37%), Insight Advisors LLC PA (0.67%), James J. Burns & Company LLC (0.35%) and Comprehensive Money Management Services LLC (0.34%). How do I buy shares of Global X Genomics & Biotechnology ETF? Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Global X Genomics & Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Genomics & Biotechnology ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Teladoc Health (TDOC), Intel (INTC), Alibaba Group (BABA) and PayPal (PYPL). Fund Details IssuerGlobal X Fund NameGlobal X Genomics & Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:GNOM Inception Date4/5/2019 Fund ManagerChang Kim, James Ong, Nam To, Wayne Xie Webwww.completegenomics.com Phone+1-650-9432800Fund Focus Asset ClassEquity BenchmarkSolactive Genomics Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings41 Fund Statistics Assets Under Management$49.08 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorGlobal X Management Company LLC AdvisorGlobal X Management Company LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerSusquehanna Options OptionableN/A Short Interest24,100 shs Miscellaneous Outstanding Shares6,060,000Beta1.03 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report Top 10 GNOM HoldingsNatera (NASDAQ:NTRA)Holding Weight: 6.93%Qiagen (NYSE:QGEN)Holding Weight: 5.53%Veracyte (NASDAQ:VCYT)Holding Weight: 5.41%BioMarin Pharmaceutical (NASDAQ:BMRN)Holding Weight: 5.02%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 4.67%BioNTech (NASDAQ:BNTX)Holding Weight: 4.64%Agilent Technologies (NYSE:A)Holding Weight: 4.63%Bio-Techne (NASDAQ:TECH)Holding Weight: 4.48%CRISPR Therapeutics (NASDAQ:CRSP)Holding Weight: 4.18%Legend Biotech (NASDAQ:LEGN)Holding Weight: 4.09%Full Holdings DetailsGNOM Sector ExposureGNOM Industry Exposure This page (NASDAQ:GNOM) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
